{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T16:11:38Z","timestamp":1785859898929,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T00:00:00Z","timestamp":1726617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Public Health"],"DOI":"10.1186\/s13690-024-01392-4","type":"journal-article","created":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:07:34Z","timestamp":1726837654000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Analysis of factors affecting the length of hospitalization of patients with Clostridioides difficile infection: a cross-sectional study"],"prefix":"10.1186","volume":"82","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5472-1485","authenticated-orcid":false,"given":"Jaros\u0142aw","family":"Drobnik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-451X","authenticated-orcid":false,"given":"Piotr","family":"Pobrotyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2390-8113","authenticated-orcid":false,"given":"\u0160tef\u00e1nia","family":"Moricov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3624-3691","authenticated-orcid":false,"given":"Katarzyna","family":"Madziarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-6309","authenticated-orcid":false,"given":"Mateusz","family":"Baran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,18]]},"reference":[{"key":"1392_CR1","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4161\/gmic.19399","volume":"3","author":"G Vedantam","year":"2012","unstructured":"Vedantam G, Clark A, Chu M, McQuade R, Mallozzi M, Viswanathan VK. Clostridium difficile infection. Gut Microbes. 2012;3:121\u201334.","journal-title":"Gut Microbes"},{"key":"1392_CR2","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/femsre\/fux048","volume":"41","author":"R Chandrasekaran","year":"2017","unstructured":"Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev. 2017;41:723\u201350.","journal-title":"FEMS Microbiol Rev"},{"key":"1392_CR3","first-page":"ITC49 \u201364","volume":"169","author":"AY Guh","year":"2018","unstructured":"Guh AY, Kutty PK. Clostridioides difficile Infection. Ann Intern Med. 2018;169:ITC49-64.","journal-title":"Ann Intern Med."},{"key":"1392_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192315670","volume":"19","author":"ZM Kiersnowska","year":"2022","unstructured":"Kiersnowska ZM, Lemiech-Mirowska E, Micha\u0142kiewicz M, Sierocka A, Marczak M. Detection and Analysis of Clostridioides difficile Spores in a Hospital Environment. Int J Environ Res Public Health. 2022;19: 15670.","journal-title":"Int J Environ Res Public Health"},{"key":"1392_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms11040845","volume":"11","author":"R Markovska","year":"2023","unstructured":"Markovska R, Dimitrov G, Gergova R, Boyanova L. Clostridioides difficile, a New \u201cSuperbug.\u201d Microorganisms. 2023;11: 845.","journal-title":"Microorganisms"},{"key":"1392_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.20411\/pai.v2i3.221","volume":"2","author":"MM Nerandzic","year":"2017","unstructured":"Nerandzic MM, Donskey CJ. Sensitizing clostridium difficile spores with germinants on skin and environmental surfaces represents a new strategy for reducing spores via ambient mechanisms. Pathog Immun. 2017;2:404\u201321.","journal-title":"Pathog Immun"},{"key":"1392_CR7","first-page":"319","volume":"19","author":"BJ Gawey","year":"2023","unstructured":"Gawey BJ, Khanna S. Clostridioides difficile infection: landscape and microbiome therapeutics. Gastroenterol Hepatol. 2023;19:319\u201328.","journal-title":"Gastroenterol Hepatol"},{"key":"1392_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1398018","volume":"15","author":"JR Chen See","year":"2024","unstructured":"Chen See JR, Leister J, Wright JR, Kruse PI, Khedekar MV, Besch CE, et al. Clostridioides difficile infection is associated with differences in transcriptionally active microbial communities. Front Microbiol. 2024;15: 1398018.","journal-title":"Front Microbiol"},{"key":"1392_CR9","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/S1473-3099(05)70215-2","volume":"5","author":"S Aslam","year":"2005","unstructured":"Aslam S, Hamill RJ, Musher DM. Treatment of Clostridium difficile-associated disease: old therapies and new strategies. Lancet Infect Dis. 2005;5:549\u201357.","journal-title":"Lancet Infect Dis"},{"key":"1392_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.anaerobe.2022.102518","volume":"74","author":"P Spigaglia","year":"2022","unstructured":"Spigaglia P. Clostridioides difficile infection (CDI) during the COVID-19 pandemic. Anaerobe. 2022;74: 102518.","journal-title":"Anaerobe"},{"key":"1392_CR11","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.09.010407","volume":"9","author":"E Balsells","year":"2019","unstructured":"Balsells E, Shi T, Leese C, Lyell I, Burrows J, Wiuff C, et al. Global burden of Clostridium difficile infections: a systematic review and meta-analysis. J Glob Health. 2019;9: 010407.","journal-title":"J Glob Health"},{"key":"1392_CR12","doi-asserted-by":"publisher","first-page":"224","DOI":"10.26444\/aaem\/119321","volume":"28","author":"Z Kiersnowska","year":"2021","unstructured":"Kiersnowska Z, Lemiech-Mirowska E, Ginter-Kramarczyk D, Kruszelnicka I, Micha\u0142kiewicz M, Marczak M. Problems of Clostridium difficile infection (CDI) in Polish healthcare units. Ann Agric Environ Med. 2021;28:224\u201330.","journal-title":"Ann Agric Environ Med"},{"key":"1392_CR13","unstructured":"National Institute of Public Health NIH - National Research Institute Department of Epidemiology and Surveillance of Infectious Diseases and Chief Sanitary Inspectorate, Department of Epidemic Prevention and Border Sanitary Protection. Infectious diseases and poisonings in Poland in 2021. Warsaw, Poland; 2022."},{"issue":"Suppl 4","key":"1392_CR14","first-page":"S63","volume":"22","author":"MJT Crobach","year":"2016","unstructured":"Crobach MJT, Planche T, Eckert C, Barbut F, Terveer EM, Dekkers OM, et al. European Society of Clinical Microbiology and Infectious Diseases: update of the diagnostic guidance document for Clostridium difficile infection. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2016;22(Suppl 4):S63-81.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"1392_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1136\/jcp.2010.080135","volume":"64","author":"T Planche","year":"2011","unstructured":"Planche T, Wilcox M. Reference assays for Clostridium difficile infection: one or two gold standards? J Clin Pathol. 2011;64:1\u20135.","journal-title":"J Clin Pathol"},{"key":"1392_CR16","doi-asserted-by":"publisher","first-page":"106002802412396","DOI":"10.1177\/10600280241239685","volume":"14","author":"NN Pettit","year":"2024","unstructured":"Pettit NN, Shaeer KM, Chahine EB. Live biotherapeutic products for the prevention of recurrent clostridioides difficile infection. Ann Pharmacother. 2024;14:10600280241239684.","journal-title":"Ann Pharmacother"},{"key":"1392_CR17","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.14309\/ajg.0000000000001278","volume":"116","author":"CR Kelly","year":"2021","unstructured":"Kelly CR, Fischer M, Allegretti JR, LaPlante K, Stewart DB, Limketkai BN, et al. ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. Am J Gastroenterol. 2021;116:1124\u201347.","journal-title":"Am J Gastroenterol"},{"key":"1392_CR18","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","volume":"73","author":"S Johnson","year":"2021","unstructured":"Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis Off Publ Infect Dis Soc Am. 2021;73:e1029\u201344.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"issue":"Suppl 2","key":"1392_CR19","first-page":"S1","volume":"27","author":"J van Prehn","year":"2021","unstructured":"van Prehn J, Reigadas E, Vogelzang EH, Bouza E, Hristea A, Guery B, et al. European society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis. 2021;27(Suppl 2):S1-21.","journal-title":"Clin Microbiol Infect Off Publ Eur Soc Clin Microbiol Infect Dis"},{"key":"1392_CR20","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1186\/s12879-016-1786-6","volume":"16","author":"S Zhang","year":"2016","unstructured":"Zhang S, Palazuelos-Munoz S, Balsells EM, Nair H, Chit A, Kyaw MH. Cost of hospital management of Clostridium difficile infection in United States-a meta-analysis and modelling study. BMC Infect Dis. 2016;16:447.","journal-title":"BMC Infect Dis"},{"key":"1392_CR21","unstructured":"Australian Commission on Safety and Quality in Health Care. Monitoring Clostridioides difficile infection (CDI) in Australia. Sydeny; 2018. https:\/\/www.safetyandquality.gov.au\/our-work\/infection-prevention-and-control\/clostridioides-difficile-infection-monitoring-australia."},{"key":"1392_CR22","first-page":"263","volume":"81","author":"M Pirson","year":"2018","unstructured":"Pirson M, Poirrier J-E, Joubert S, Van den Bulcke J, Leclercq P, Avena L, et al. Evaluation of the cost and length of hospital stays related to the management of an intestinal Clostridium difficile infection. Acta Gastro-Enterol Belg. 2018;81:263\u20138.","journal-title":"Acta Gastro-Enterol Belg"},{"key":"1392_CR23","first-page":"105","volume":"58","author":"M Dr\u00f3\u017cd\u017c","year":"2018","unstructured":"Dr\u00f3\u017cd\u017c M, Biesiada G, Pi\u0105tek A, \u015awistek M, Michalak M, Sta\u017cyk K, et al. Analysis of risk factors and outcomes of Clostridium difficile infection. Folia Med Cracov. 2018;58:105\u201316.","journal-title":"Folia Med Cracov"}],"container-title":["Archives of Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-024-01392-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13690-024-01392-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13690-024-01392-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,20]],"date-time":"2024-09-20T13:07:40Z","timestamp":1726837660000},"score":1,"resource":{"primary":{"URL":"https:\/\/archpublichealth.biomedcentral.com\/articles\/10.1186\/s13690-024-01392-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,18]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1392"],"URL":"https:\/\/doi.org\/10.1186\/s13690-024-01392-4","relation":{},"ISSN":["2049-3258"],"issn-type":[{"value":"2049-3258","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,18]]},"assertion":[{"value":"15 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local Bioethics Committee of the Wroclaw Medical University, Poland (approval no. KB\u2013611\/2018). The study adhered to the principles of the Helsinki Declaration and Good Clinical Practice. All participants provided written informed consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"158"}}